Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
579
-84
-13% -$28.8K 0.04% 172
2026
Q1
$233K Sell
663
-542
-45% -$193K 0.02% 172
2025
Q4
$395K Buy
1,205
+54
+5% +$17.1K 0.03% 134
2025
Q3
$325K Buy
1,151
+51
+5% +$14.8K 0.03% 140
2025
Q2
$307K Buy
1,100
+69
+7% +$19.5K 0.03% 132
2025
Q1
$321K Buy
1,031
+1
+0.1% +$295 0.04% 135
2024
Q4
$268K Buy
1,030
+193
+23% +$57.3K 0.04% 133
2024
Q3
$270K Buy
+837
New +$274K 0.04% 129

Other funds holding AMGN

49 Wealth Management's AMGN Position: Q2 2026 in Review

49 Wealth Management reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $28.8K and leaving 579 shares worth $209K. The position accounts for 0.04% of the portfolio, ranked #172.

49 Wealth Management first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $395K in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • 49 Wealth Management held 579 shares of Amgen worth $209K as of Q2 2026.
  • 49 Wealth Management sold 84 Amgen shares in Q2 2026, an estimated $28.8K.
  • Amgen made up 0.04% of 49 Wealth Management's portfolio in Q2 2026, its #172 holding.
  • 49 Wealth Management first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 49 Wealth Management's Amgen position peaked at $395K in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.